Hereditary pulmonary alveolar proteinosis: Pathogenesis, presentation, diagnosis, and therapy

Takuji Suzuki, Takuro Sakagami, Lisa R. Young, Brenna C. Carey, Robert E. Wood, Maurizio Luisetti, Susan E. Wert, Bruce K. Rubin, Katharine Kevill, Claudia Chalk, Jeffrey A. Whitsett, Carrie Stevens, Lawrence M. Nogee, Ilaria Campo, Bruce C. Trapnell

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Rationale: We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor function, and increased GM-CSF. Objectives: Increased serum GM-CSF may be useful to identify individuals with PAP caused by GM-CSF receptor dysfunction. Methods: We screened 187 patients referred to us for measurement of GM-CSF autoantibodies to diagnose autoimmune PAP. Five were children with PAP and increased serum GM-CSF but without GM-CSF autoantibodies or any disease causing secondary PAP; all were studied with family members, subsequently identified patients, and controls. Measurement and Main Results: Eight children (seven female, one male) were identified with PAP caused by recessive CSF2RA mutations. Six presented with progressive dyspnea of insidious onset at 4.8 ± 1.6 years and two were asymptomatic at ages 5 and 8 years. Radiologic and histopathologic manifestations were similar to those of autoimmune PAP. Molecular analysis demonstrated that GM-CSF signaling was absent in six and severely reduced in two patients. The GM-CSF receptor β chain was detected in all patients, whereas the α chain was absent in six and abnormal in two, paralleling the GM-CSF signaling defects. Genetic analysis revealed multiple distinct CSF2RA abnormalities, including missense, duplication, frameshift, and nonsense mutations; exon and gene deletion; and cryptic alternative splicing. All symptomatic patients responded well to whole-lung lavage therapy. Conclusions: CSF2RA mutations cause a genetic form of PAP presenting as insidious, progressive dyspnea in children that can be diagnosed by a combination of characteristic radiologic findings and blood tests and treated successfully by whole-lung lavage.

Original languageEnglish
Pages (from-to)1292-1304
Number of pages13
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume182
Issue number10
DOIs
Publication statusPublished - Nov 15 2010

Fingerprint

Pulmonary Alveolar Proteinosis
Granulocyte-Macrophage Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor Receptors
Bronchoalveolar Lavage
Dyspnea
Autoantibodies
Therapeutics
Frameshift Mutation
Mutation
Nonsense Codon
Gene Deletion
Alternative Splicing
Hematologic Tests
Missense Mutation
Serum
Exons

Keywords

  • Alveolar macrophage
  • Genetic disease
  • Gm-csf receptor
  • Surfactant
  • Whole lung lavage

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Suzuki, T., Sakagami, T., Young, L. R., Carey, B. C., Wood, R. E., Luisetti, M., ... Trapnell, B. C. (2010). Hereditary pulmonary alveolar proteinosis: Pathogenesis, presentation, diagnosis, and therapy. American Journal of Respiratory and Critical Care Medicine, 182(10), 1292-1304. https://doi.org/10.1164/rccm.201002-0271OC

Hereditary pulmonary alveolar proteinosis : Pathogenesis, presentation, diagnosis, and therapy. / Suzuki, Takuji; Sakagami, Takuro; Young, Lisa R.; Carey, Brenna C.; Wood, Robert E.; Luisetti, Maurizio; Wert, Susan E.; Rubin, Bruce K.; Kevill, Katharine; Chalk, Claudia; Whitsett, Jeffrey A.; Stevens, Carrie; Nogee, Lawrence M.; Campo, Ilaria; Trapnell, Bruce C.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 182, No. 10, 15.11.2010, p. 1292-1304.

Research output: Contribution to journalArticle

Suzuki, T, Sakagami, T, Young, LR, Carey, BC, Wood, RE, Luisetti, M, Wert, SE, Rubin, BK, Kevill, K, Chalk, C, Whitsett, JA, Stevens, C, Nogee, LM, Campo, I & Trapnell, BC 2010, 'Hereditary pulmonary alveolar proteinosis: Pathogenesis, presentation, diagnosis, and therapy', American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 10, pp. 1292-1304. https://doi.org/10.1164/rccm.201002-0271OC
Suzuki, Takuji ; Sakagami, Takuro ; Young, Lisa R. ; Carey, Brenna C. ; Wood, Robert E. ; Luisetti, Maurizio ; Wert, Susan E. ; Rubin, Bruce K. ; Kevill, Katharine ; Chalk, Claudia ; Whitsett, Jeffrey A. ; Stevens, Carrie ; Nogee, Lawrence M. ; Campo, Ilaria ; Trapnell, Bruce C. / Hereditary pulmonary alveolar proteinosis : Pathogenesis, presentation, diagnosis, and therapy. In: American Journal of Respiratory and Critical Care Medicine. 2010 ; Vol. 182, No. 10. pp. 1292-1304.
@article{1e6b49c7403b447bae05ab149ad5f0f9,
title = "Hereditary pulmonary alveolar proteinosis: Pathogenesis, presentation, diagnosis, and therapy",
abstract = "Rationale: We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor function, and increased GM-CSF. Objectives: Increased serum GM-CSF may be useful to identify individuals with PAP caused by GM-CSF receptor dysfunction. Methods: We screened 187 patients referred to us for measurement of GM-CSF autoantibodies to diagnose autoimmune PAP. Five were children with PAP and increased serum GM-CSF but without GM-CSF autoantibodies or any disease causing secondary PAP; all were studied with family members, subsequently identified patients, and controls. Measurement and Main Results: Eight children (seven female, one male) were identified with PAP caused by recessive CSF2RA mutations. Six presented with progressive dyspnea of insidious onset at 4.8 ± 1.6 years and two were asymptomatic at ages 5 and 8 years. Radiologic and histopathologic manifestations were similar to those of autoimmune PAP. Molecular analysis demonstrated that GM-CSF signaling was absent in six and severely reduced in two patients. The GM-CSF receptor β chain was detected in all patients, whereas the α chain was absent in six and abnormal in two, paralleling the GM-CSF signaling defects. Genetic analysis revealed multiple distinct CSF2RA abnormalities, including missense, duplication, frameshift, and nonsense mutations; exon and gene deletion; and cryptic alternative splicing. All symptomatic patients responded well to whole-lung lavage therapy. Conclusions: CSF2RA mutations cause a genetic form of PAP presenting as insidious, progressive dyspnea in children that can be diagnosed by a combination of characteristic radiologic findings and blood tests and treated successfully by whole-lung lavage.",
keywords = "Alveolar macrophage, Genetic disease, Gm-csf receptor, Surfactant, Whole lung lavage",
author = "Takuji Suzuki and Takuro Sakagami and Young, {Lisa R.} and Carey, {Brenna C.} and Wood, {Robert E.} and Maurizio Luisetti and Wert, {Susan E.} and Rubin, {Bruce K.} and Katharine Kevill and Claudia Chalk and Whitsett, {Jeffrey A.} and Carrie Stevens and Nogee, {Lawrence M.} and Ilaria Campo and Trapnell, {Bruce C.}",
year = "2010",
month = "11",
day = "15",
doi = "10.1164/rccm.201002-0271OC",
language = "English",
volume = "182",
pages = "1292--1304",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society - AJRCCM",
number = "10",

}

TY - JOUR

T1 - Hereditary pulmonary alveolar proteinosis

T2 - Pathogenesis, presentation, diagnosis, and therapy

AU - Suzuki, Takuji

AU - Sakagami, Takuro

AU - Young, Lisa R.

AU - Carey, Brenna C.

AU - Wood, Robert E.

AU - Luisetti, Maurizio

AU - Wert, Susan E.

AU - Rubin, Bruce K.

AU - Kevill, Katharine

AU - Chalk, Claudia

AU - Whitsett, Jeffrey A.

AU - Stevens, Carrie

AU - Nogee, Lawrence M.

AU - Campo, Ilaria

AU - Trapnell, Bruce C.

PY - 2010/11/15

Y1 - 2010/11/15

N2 - Rationale: We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor function, and increased GM-CSF. Objectives: Increased serum GM-CSF may be useful to identify individuals with PAP caused by GM-CSF receptor dysfunction. Methods: We screened 187 patients referred to us for measurement of GM-CSF autoantibodies to diagnose autoimmune PAP. Five were children with PAP and increased serum GM-CSF but without GM-CSF autoantibodies or any disease causing secondary PAP; all were studied with family members, subsequently identified patients, and controls. Measurement and Main Results: Eight children (seven female, one male) were identified with PAP caused by recessive CSF2RA mutations. Six presented with progressive dyspnea of insidious onset at 4.8 ± 1.6 years and two were asymptomatic at ages 5 and 8 years. Radiologic and histopathologic manifestations were similar to those of autoimmune PAP. Molecular analysis demonstrated that GM-CSF signaling was absent in six and severely reduced in two patients. The GM-CSF receptor β chain was detected in all patients, whereas the α chain was absent in six and abnormal in two, paralleling the GM-CSF signaling defects. Genetic analysis revealed multiple distinct CSF2RA abnormalities, including missense, duplication, frameshift, and nonsense mutations; exon and gene deletion; and cryptic alternative splicing. All symptomatic patients responded well to whole-lung lavage therapy. Conclusions: CSF2RA mutations cause a genetic form of PAP presenting as insidious, progressive dyspnea in children that can be diagnosed by a combination of characteristic radiologic findings and blood tests and treated successfully by whole-lung lavage.

AB - Rationale: We identified a 6-year-old girl with pulmonary alveolar proteinosis (PAP), impaired granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor function, and increased GM-CSF. Objectives: Increased serum GM-CSF may be useful to identify individuals with PAP caused by GM-CSF receptor dysfunction. Methods: We screened 187 patients referred to us for measurement of GM-CSF autoantibodies to diagnose autoimmune PAP. Five were children with PAP and increased serum GM-CSF but without GM-CSF autoantibodies or any disease causing secondary PAP; all were studied with family members, subsequently identified patients, and controls. Measurement and Main Results: Eight children (seven female, one male) were identified with PAP caused by recessive CSF2RA mutations. Six presented with progressive dyspnea of insidious onset at 4.8 ± 1.6 years and two were asymptomatic at ages 5 and 8 years. Radiologic and histopathologic manifestations were similar to those of autoimmune PAP. Molecular analysis demonstrated that GM-CSF signaling was absent in six and severely reduced in two patients. The GM-CSF receptor β chain was detected in all patients, whereas the α chain was absent in six and abnormal in two, paralleling the GM-CSF signaling defects. Genetic analysis revealed multiple distinct CSF2RA abnormalities, including missense, duplication, frameshift, and nonsense mutations; exon and gene deletion; and cryptic alternative splicing. All symptomatic patients responded well to whole-lung lavage therapy. Conclusions: CSF2RA mutations cause a genetic form of PAP presenting as insidious, progressive dyspnea in children that can be diagnosed by a combination of characteristic radiologic findings and blood tests and treated successfully by whole-lung lavage.

KW - Alveolar macrophage

KW - Genetic disease

KW - Gm-csf receptor

KW - Surfactant

KW - Whole lung lavage

UR - http://www.scopus.com/inward/record.url?scp=78349301199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349301199&partnerID=8YFLogxK

U2 - 10.1164/rccm.201002-0271OC

DO - 10.1164/rccm.201002-0271OC

M3 - Article

C2 - 20622029

AN - SCOPUS:78349301199

VL - 182

SP - 1292

EP - 1304

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 10

ER -